• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

典型Wnt抑制剂卡利他汀的转基因表达与外周血中循环CD19 B淋巴细胞减少有关。

Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19 B lymphocytes in the peripheral blood.

作者信息

McBride Jeffrey D, Liu Xiaochen, Berry William L, Janknecht Ralf, Cheng Rui, Zhou Kelu, Badiavas Evangelos V, Ma Jian-Xing

机构信息

Department of Cell Biology, University of Oklahoma Health Sciences Center, BSEB 328B, 941 Stanton L. Young Blvd, Oklahoma City, OK, 73104-5020, USA.

Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

出版信息

Int J Hematol. 2017 Jun;105(6):748-757. doi: 10.1007/s12185-017-2205-5. Epub 2017 Mar 15.

DOI:10.1007/s12185-017-2205-5
PMID:28299632
Abstract

Members of the family of serine proteinase inhibitors, such as kallistatin, have been shown to inhibit canonical Wnt-TCF/LEF-β-catenin signaling via their interactions with the Wnt co-receptor LRP6. Yet the effects of transgenic overexpression of anti-Wnt serpins on hematopoiesis and lymphopoiesis are not well known. We studied the effects of human kallistatin (SERPINA4) on Wnt reporter activity in various cell types throughout the hematopoietic system and associated impacts on circulating white blood cell profiles. Transgenic overexpression of kallistatin suppressed Wnt-TCF/LEF-β-catenin signaling in bone marrow, as demonstrated using a Wnt reporter mouse. Further, kallistatin overexpression and treatment were associated with reduced Wnt-TCF/LEF-β-catenin activity in CD34 c-kit bone marrow cells and CD19 B lymphocytes, with reduced levels of these populations in bone marrow and peripheral circulation, respectively. The presence of CD3CD4, CD3CD8, and CD3 NK1.1 T lymphocytes were not significantly affected. Our data suggest that overexpression of kallistatin interferes with lymphopoiesis, ultimately impacting the level of circulating CD19 B lymphocytes.

摘要

丝氨酸蛋白酶抑制剂家族的成员,如激肽释放酶抑制蛋白,已被证明可通过与Wnt共受体LRP6相互作用来抑制经典的Wnt-TCF/LEF-β-连环蛋白信号传导。然而,抗Wnt丝氨酸蛋白酶抑制剂转基因过表达对造血和淋巴细胞生成的影响尚不清楚。我们研究了人激肽释放酶抑制蛋白(SERPINA4)对整个造血系统中各种细胞类型的Wnt报告基因活性的影响以及对循环白细胞谱的相关影响。使用Wnt报告基因小鼠证明,激肽释放酶抑制蛋白的转基因过表达抑制了骨髓中的Wnt-TCF/LEF-β-连环蛋白信号传导。此外,激肽释放酶抑制蛋白的过表达和处理与CD34 c-kit骨髓细胞和CD19 B淋巴细胞中Wnt-TCF/LEF-β-连环蛋白活性降低有关,分别导致骨髓和外周循环中这些细胞群的水平降低。CD3CD4、CD3CD8和CD3 NK1.1 T淋巴细胞的存在没有受到显著影响。我们的数据表明,激肽释放酶抑制蛋白的过表达会干扰淋巴细胞生成,最终影响循环CD19 B淋巴细胞的水平。

相似文献

1
Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19 B lymphocytes in the peripheral blood.典型Wnt抑制剂卡利他汀的转基因表达与外周血中循环CD19 B淋巴细胞减少有关。
Int J Hematol. 2017 Jun;105(6):748-757. doi: 10.1007/s12185-017-2205-5. Epub 2017 Mar 15.
2
The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis.经典Wnt信号通路在淋巴细胞生成和造血过程中发挥重要作用。
Eur J Immunol. 2008 Jul;38(7):1788-94. doi: 10.1002/eji.200738118.
3
Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis.人骨髓B淋巴细胞生成中的Wnt表达与经典Wnt信号通路
BMC Immunol. 2006 Jun 29;7:13. doi: 10.1186/1471-2172-7-13.
4
Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.激肽释放酶抑制物通过与经典 Wnt 通路相互作用产生抗血管生成和抗神经炎症作用。
Diabetes. 2013 Dec;62(12):4228-38. doi: 10.2337/db12-1710. Epub 2013 Jul 24.
5
Canonical Wnt signalling plays essential roles.经典Wnt信号传导发挥着重要作用。
Eur J Immunol. 2009 Dec;39(12):3582-3; author reply 3583-4. doi: 10.1002/eji.200838982.
6
Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling.在患有糖尿病微血管并发症的患者中,一种抗血管生成的丝氨酸蛋白酶抑制剂的循环水平升高,通过抑制 Wnt 信号通路来损害伤口愈合。
J Invest Dermatol. 2014 Jun;134(6):1725-1734. doi: 10.1038/jid.2014.40. Epub 2014 Jan 24.
7
Wnt signaling in lymphopoiesis.淋巴细胞生成中的Wnt信号传导。
Curr Top Microbiol Immunol. 2005;290:225-52. doi: 10.1007/3-540-26363-2_10.
8
Pathogenic Role of Diabetes-Induced Overexpression of Kallistatin in Corneal Wound Healing Deficiency Through Inhibition of Canonical Wnt Signaling.糖尿病诱导 kallistatin 过表达通过抑制经典 Wnt 信号在角膜愈合缺陷中的致病作用。
Diabetes. 2022 Apr 1;71(4):747-761. doi: 10.2337/db21-0740.
9
Overexpression of ICAT highlights a role for catenin-mediated canonical Wnt signalling in early T cell development.ICAT的过表达凸显了连环蛋白介导的经典Wnt信号通路在早期T细胞发育中的作用。
Eur J Immunol. 2006 Sep;36(9):2376-83. doi: 10.1002/eji.200535721.
10
Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.分化诱导因子-1改变经典Wnt信号通路并抑制成骨样细胞系中碱性磷酸酶的表达。
J Bone Miner Res. 2006 Aug;21(8):1307-16. doi: 10.1359/jbmr.060512.

引用本文的文献

1
Extracellular Vesicles as a Neprilysin Delivery System Memory Improvement in Alzheimer's Disease.细胞外囊泡作为一种中性内肽酶递送系统改善阿尔茨海默病的记忆功能
Iran J Pharm Res. 2020 Spring;19(2):45-60. doi: 10.22037/ijpr.2020.112062.13508.
2
Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells.激肽释放酶物抑制因子通过抑制 T 细胞的活化来减轻实验性自身免疫性葡萄膜炎。
Front Immunol. 2020 May 21;11:975. doi: 10.3389/fimmu.2020.00975. eCollection 2020.
3
Wnt Signaling in vascular eye diseases.Wnt 信号通路在血管性眼病中的作用。

本文引用的文献

1
TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells.TCF-1 和 LEF-1 在 Th-POK 的上游发挥作用,促进 CD4(+)T 细胞命运,并与 Runx3 相互作用,在 CD8(+)T 细胞中沉默 Cd4。
Nat Immunol. 2014 Jul;15(7):646-656. doi: 10.1038/ni.2897. Epub 2014 May 18.
2
Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling.在患有糖尿病微血管并发症的患者中,一种抗血管生成的丝氨酸蛋白酶抑制剂的循环水平升高,通过抑制 Wnt 信号通路来损害伤口愈合。
J Invest Dermatol. 2014 Jun;134(6):1725-1734. doi: 10.1038/jid.2014.40. Epub 2014 Jan 24.
3
Prog Retin Eye Res. 2019 May;70:110-133. doi: 10.1016/j.preteyeres.2018.11.008. Epub 2018 Dec 1.
4
Analysis of Polymorphisms in the Mediator Complex Subunit 13-like (Med13L) Gene in the Context of Immune Function and Development of Experimental Arthritis.中介复合物亚基 13 样(Med13L)基因多态性与免疫功能及实验性关节炎发病机制的相关性分析。
Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):365-377. doi: 10.1007/s00005-018-0516-8. Epub 2018 Jun 27.
Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.
激肽释放酶抑制物通过与经典 Wnt 通路相互作用产生抗血管生成和抗神经炎症作用。
Diabetes. 2013 Dec;62(12):4228-38. doi: 10.2337/db12-1710. Epub 2013 Jul 24.
4
A localized Wnt signal orients asymmetric stem cell division in vitro.局部化的 Wnt 信号在体外定向不对称的干细胞分裂。
Science. 2013 Mar 22;339(6126):1445-8. doi: 10.1126/science.1231077.
5
Wnt signaling in skin development, homeostasis, and disease.Wnt 信号在皮肤发育、稳态和疾病中的作用。
Cold Spring Harb Perspect Biol. 2013 Feb 1;5(2):a008029. doi: 10.1101/cshperspect.a008029.
6
Identification of a novel inhibitor of the canonical Wnt pathway.鉴定经典 Wnt 通路的新型抑制剂。
Mol Cell Biol. 2011 Jul;31(14):3038-51. doi: 10.1128/MCB.01211-10. Epub 2011 May 16.
7
The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels.染色质重塑酶 BRG1 通过两种水平调节血管 Wnt 信号通路。
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2282-7. doi: 10.1073/pnas.1013751108. Epub 2011 Jan 24.
8
Increased serum kallistatin levels in type 1 diabetes patients with vascular complications.1型糖尿病合并血管并发症患者血清血管抑素水平升高。
J Angiogenes Res. 2010 Sep 22;2:19. doi: 10.1186/2040-2384-2-19.
9
Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.Wnt/β-catenin 信号通路在 T 细胞免疫及肿瘤免疫治疗中的作用
Clin Cancer Res. 2010 Oct 1;16(19):4695-701. doi: 10.1158/1078-0432.CCR-10-0356. Epub 2010 Aug 5.
10
Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family.阻断 Wnt 通路:丝氨酸蛋白酶抑制剂家族中血管生成抑制剂的统一机制。
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6900-5. doi: 10.1073/pnas.0906764107. Epub 2010 Mar 29.